REVIEW article
Front. Pediatr.
Sec. Obstetric and Pediatric Pharmacology
Volume 13 - 2025 | doi: 10.3389/fped.2025.1571790
Value of adding 0.01% Atropine With Orthokeratology for Myopia in Children: An updated meta-analysis of randomized controlled trials
Provisionally accepted
- The Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: This systematic review and meta-analysis aimed to compare outcomes of 0.01% atropine with orthokeratology (AOK) vs orthokeratology (OK) alone for slowing the progression of myopia in children. Methods: MEDLINE via PubMed, Embase, Scopus, Web of Science, CENTRAL (Cochrane Central Register of Controlled Trials), Chinese electronic databases of VIP, and Wanfang were searched from inception until 19 th August 2024 for randomized controlled trials (RCTs) about the review topic. The primary outcome was a change in axial length (AL) (mm). Secondary outcomes were spherical equivalent refraction (SER) (Diopter), pupil diameter (PD) (mm), amplitude of accommodation (AA) (Diopter), and intraocular pressure (IOP) (mmHg). Results: 10 articles corresponding to eight RCTs were included. Meta-analysis found that change in AL was significantly reduced with AOK as compared to OK alone at 6 months (MD: -0.10 95% CI: -0.14, -0.06 I 2 =48%), 12 months (MD: -0.08 95% CI: -0.10, -0.07 I 2 =0%) and 24 months (MD: -0.14 95% CI: -0.19, -0.08 I 2 =0%). Pooled analysis found that AOK did not reduce the progression of SER (MD: 0.06 95% CI: -0.00, 0.12 I 2 =7%) and increased PD (MD: 0.63 95% CI: 0.40, 0.85 I 2 =86%) as compared to OK alone. Pooled analysis also found a tendency of reduced AA with AOK as compared to OK alone but without significant results (MD: -0.45 95% CI: -1.00, 0.10 I 2 =59%). Meta-analysis failed to show a statistically significant difference in change of IOP between AOK and OK (MD: -0.49 95% CI: -1.48, 0.50 I 2 =51%). Conclusions: AOK seems to be more efficacious in slowing the progression of myopia in children as compared to OK alone.
Keywords: Myopia, Orthokeratology, Atropine, nearsightedness, Meta-analysis
Received: 04 Apr 2025; Accepted: 19 May 2025.
Copyright: © 2025 Tu, Ying, Ni, Zhang and Hu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Weiping Hu, The Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.